Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_assertion description "[The objective of this study was to investigate the therapeutic potential of ���I added to doxorubicin therapy in multidrug resistance (MDR) mouse colon cancer coexpressing the MDR1 small hairpin RNA (shRNA) and human sodium iodide symporter (hNIS) gene in a single gene construct and to visualize the antitumor effects using molecular nuclear imaging.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_assertion evidence source_evidence_literature NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_assertion SIO_000772 21204761 NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_assertion wasDerivedFrom befree-20150227 NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_assertion wasGeneratedBy ECO_0000203 NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.
- befree-20150227 importedOn "2015-02-27" NP868677.RARX6r5NKoQFuIufcp_wADmSSfMWCrWcbosXIzpN-75xk130_provenance.